Literature DB >> 9695727

Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein.

H Wakasugi1, I Yano, T Ito, T Hashida, T Futami, R Nohara, S Sasayama, K Inui.   

Abstract

We present a digoxin-clarithromycin interaction in two patients in whom digoxin concentrations were unexpectedly increased. The ratio of renal digoxin clearance to creatinine clearance in one patient was lower during the concomitant administration of clarithromycin (0.64 and 0.73) than that after cessation of clarithromycin administration (1.30 +/- 0.20; mean +/- SD). Because P-glycoprotein could play an important role in the renal secretion of digoxin, we hypothesized that clarithromycin decreases renal digoxin excretion by inhibiting P-glycoprotein-mediated transport. Digoxin transport was evaluated with use of a kidney epithelial cell line, which expresses the human P-glycoprotein on the apical membrane by transfection with MDR1 complementary deoxyribonucleic acid. Clarithromycin inhibited the transcellular transport of digoxin from the basolateral to the apical side in a concentration-dependent manner and concomitantly increased the cellular accumulation of digoxin. These results suggest that clarithromycin may inhibit the P-glycoprotein-mediated tubular secretion of digoxin, and this interaction mechanism may contribute to an increase in the serum digoxin concentration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9695727     DOI: 10.1016/S0009-9236(98)90030-3

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  41 in total

1.  Carrier-mediated transport of macrolide antimicrobial agents across Caco-2 cell monolayers.

Authors:  H Saito; Y Fukasawa; Y Otsubo; K Yamada; H Sezaki; S Yamashita
Journal:  Pharm Res       Date:  2000-06       Impact factor: 4.200

Review 2.  Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin.

Authors:  J F Westphal
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

Review 3.  Measurement of renal function during drug development.

Authors:  D Craig Brater
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

4.  Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin.

Authors:  Masami Sugie; Emiko Asakura; Ying Lan Zhao; Shoko Torita; Masayuki Nadai; Kenji Baba; Kiyoyuki Kitaichi; Kenji Takagi; Kenzo Takagi; Takaaki Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

5.  Bleeding associated with coadministration of rivaroxaban and clarithromycin.

Authors:  Michael Fralick; David N Juurlink; Theodore Marras
Journal:  CMAJ       Date:  2016-01-25       Impact factor: 8.262

6.  A population-based assessment of the potential interaction between serotonin-specific reuptake inhibitors and digoxin.

Authors:  David N Juurlink; Muhammad M Mamdani; Alexander Kopp; Nathan Herrmann; Andreas Laupacis
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

7.  Common single nucleotide polymorphisms of the MDR1 gene have no influence on its mRNA expression level of normal kidney cortex and renal cell carcinoma in Japanese nephrectomized patients.

Authors:  Yuichi Uwai; Satohiro Masuda; Maki Goto; Hideyuki Motohashi; Hideyuki Saito; Masahiro Okuda; Eijirou Nakamura; Noriyuki Ito; Osamu Ogawa; Ken-Ichi Inui
Journal:  J Hum Genet       Date:  2003-12-18       Impact factor: 3.172

8.  Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes.

Authors:  Masato Saito; Norio Yasui-Furukori; Tsukasa Uno; Takenori Takahata; Kazunobu Sugawara; Akihiro Munakata; Tomonori Tateishi
Journal:  Br J Clin Pharmacol       Date:  2005-03       Impact factor: 4.335

9.  Construction of a functional transporter analysis system using MDR1 knockdown Caco-2 cells.

Authors:  Tomoko Watanabe; Reiko Onuki; Shinji Yamashita; Kazunari Taira; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

10.  Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction.

Authors:  Jens Rengelshausen; Christoph Göggelmann; Jürgen Burhenne; Klaus-Dieter Riedel; Jochen Ludwig; Johanna Weiss; Gerd Mikus; Ingeborg Walter-Sack; Walter E Haefeli
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.